follitropin delta: Clinical Trials

5 trials of follitropin delta, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Recruiting 1, Terminated 1

Follow follitropin delta: new trials by email Literature Review of follitropin delta trials Research Report on follitropin delta

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)
REKOVELLE (Follitropin Delta) - Infertility, Insemination
Phase 2RecruitingCentre Hospitalier Intercommunal Creteil802025-12-172026-04-08
A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM)
FE 999049, Placebo - Male Idiopathic Infertility
Phase 2TerminatedFerring Pharmaceuticals42022-08-162026-08-28
Higher Dose of Rekovelle in Oocyte Donors
Follitropin Delta, Recombinant - IVF
Phase 2CompletedIVI Madrid402021-09-282022-11-14
Personalized Insemination Treatment Study
Follitropin delta - Infertility, Intrauterine Insemination
Phase 2CompletedClinique Ovo1102020-01-092022-09-13
A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.
FE 999302 (1 μg) and follitropin delta, FE 999302 (2 μg) and follitropin delta, FE 999302 (4 μg) and follitropin delta - Controlled Ovarian Stimulation
Phase 2CompletedFerring Pharmaceuticals6202018-05-142023-08-31

Conditions studied

Infertility (2)

Sponsors

Ferring Pharmaceuticals (2)  ·  Centre Hospitalier Intercommunal Creteil (1)  ·  Clinique Ovo (1)  ·  IVI Madrid (1)

Countries

Spain (3)  ·  Belgium (2)  ·  Denmark (2)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Jacques Kadoch, MD (1)  ·  Nicolas Chevalier (1)

Results publications

PMID 37194068

NIH funding

2017 (1)